143 / 490
141
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
MONDAY 2 MAY 2016
Medical oncologist
Panellist: M. Di Maio (Italy)
Interventional radiologist
Panellist: A. Veltri (Italy)
Thoracic surgeon
Panellist: E. Ruffini (Italy)
Symposium
DOSE PAINTING: THOSE PENDING ISSUES
16:45 - 17:45 | ROOM 2
Dose painting is the delivery of a non-uniform dose distribution according to a spatial distribution of a
given phenotype of the tumour volume, supposedly provided by functional imaging (PET, MR...). Such
strategy would enable tailored dose escalation/redistribution in radio resistant regions of the tumour
volume, mitigating toxicity issues that would originate from a flat, homogeneous dose escalation.
Although conceptually appealing and relatively simple in its formulation, a dose painting treatment
strategy involves a complex chain of technical steps with uncertainties that could ultimately make the
delivered dose distribution unrepresentative of the actual biology of the tumour.
In this symposium, we will first define the biological and clinical rationale supporting the dose painting
concept before covering the challenges to be solved before a meaningful clinical implementation.
Chair: E. Sterpin (Belgium)
Co-chair: P. Franco (Italy)
16:45 > The promises of dose painting
Speaker: W. De Neve (Belgium)
SP-0520
17:05 > The biological rationale of dose painting: is it realistic?
Speaker: M. Alber (Denmark)
SP-0521
17:25 > Dose prescription and treatment delivery at the voxel scale: a fantasy?
Speaker: J. Lee (Belgium)
SP-0522
Symposium
ACROP
16:45 - 17:45 | ROOM 4
Since 2012 the Advisory Committee for Radiation Oncology Practice (ACROP) has taken over the re-
sponsibility for the initiation and coordination of ESTRO internal guidelines ae well as multidisciplinary
guidelines together with other scientific societies.
During this ESTRO 35 ACROP session C. Belka will present the workflow and SOP of ACROP;
K. Tanderup will give a brief overview of the ongoing and mature guidelines in the areas of brachtherapy
and physics; and, M. Niyazi will present the new guideline on 'Target volume delineation in Glioblas-
toma'.